AAAAAA
Results:
1-10
|
Results: 10
Authors:
Sharpe, S
Beer, B
Hall, G
Dennis, M
Norley, S
Cranage, M
Citation: S. Sharpe et al., Analysis of SIV-specific CTL in the rhesus macaque model of AIDS: the use of simian fibroblasts as an alternative source of target cells for chromiumrelease assays, J IMMUNOL M, 258(1-2), 2001, pp. 137-140
Authors:
Beer, B
Citation: B. Beer, Population dynamics of a Philippine rain forest people. The San Ildefonso Agta., ANTHROPOS, 95(1), 2000, pp. 253-254
Authors:
Hartmann, K
Block, A
Ferk, G
Beer, B
Vollmar, A
Lutz, H
Citation: K. Hartmann et al., Treatment of feline leukemia virus (FeLV) infection, VET MICROB, 69(1-2), 1999, pp. 111-113
Authors:
Lippa, AS
Beer, B
Cancro, R
Citation: As. Lippa et al., Overview of citalopram, J CL PSYCH, 19(5), 1999, pp. 1S-3S
Authors:
Willetts, J
Lippa, A
Beer, B
Citation: J. Willetts et al., Clinical development of citalopram, J CL PSYCH, 19(5), 1999, pp. 36S-46S
Authors:
Beer, B
Citation: B. Beer, Measurement of economic wellbeing in developing countries - International indicators versus indigenous perspective of wellbeing in Samoa, ANTHROPOS, 94(4-6), 1999, pp. 632-632
Authors:
Norley, S
Beer, B
Holzammer, S
zur Megede, J
Kurth, R
Citation: S. Norley et al., Why are the natural hosts of SIV resistant to AIDS?, IMMUNOL LET, 66(1-3), 1999, pp. 47-52
Authors:
Beer, B
Kurth, R
Bukreyev, A
Citation: B. Beer et al., Characteristics of filoviridae: Marburg and Ebola viruses, NATURWISSEN, 86(1), 1999, pp. 8-17
Authors:
Bormann, EJ
Leissner, M
Roth, M
Beer, B
Metzner, K
Citation: Ej. Bormann et al., Production of polyhydroxybutyrate by Ralstonia eutropha from protein hydrolysates, APPL MICR B, 50(5), 1998, pp. 604-607
SIVMAC vaccine studies using whole inactivated virus antigen sequentially depleted of viral proteins
Authors:
Norley, S
Beer, B
Konig, H
Jensen, F
Kurth, R
Citation: S. Norley et al., SIVMAC vaccine studies using whole inactivated virus antigen sequentially depleted of viral proteins, J MED PRIM, 27(4), 1998, pp. 184-192
Risultati:
1-10
|